Hunter syndrome is an exceedingly rare genetic disorder caused by a malfunctioning or missing enzyme. Patients with Hunter ...

Two studies show signs that the introduced DNA is functioning, but it’s too early to know if patients actually benefit. Two patients who received Sangamo’s zinc finger–based treatment for Hunter ...

The Horn of the Hunter features opinions from all sides of the debate, drawn from extensive interviews with both pro- and anti-hunt supporters across the UK. "Country people don't make their ...

Shire’s attempts to develop a drug for cognitive impairment from the rare inherited disease Hunter Syndrome has failed to produce results. The company’s Elaprase (idursulfase) is already ...

Feb. 06, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), today announced the primary analysis of the Phase 1/2 study in 47 participants with Hunter syndrome (MPS II) in the 24-week ...